The VerifiTM Prenatal Test safely and noninvasively screens for the most common chromosomal aneuploidies as early as 10 weeks gestation using a single maternal blood draw, offering the lowest test failure rate in the industry. The Verifi Prenatal Test uses sequencing technology to provide accurate information for pregnant women regardless of age or risk.
Average Turnaround Time
3.3 business days
Observed False Positives
Observed False Negatives
Why choose the VerifiTM Test?
Comprehensive portfolio with expanded panel available
Fast turnaround time
Lowest published failure rate in the industry, 0.1%
Proven superiority to traditional screening methods for the screening of common fetal aneuploidies, with reduced false positive rates (increased specificity) and increased positive predictive values (PPV)
Standard VerifiTM Test
1p36 deletion syndrome
Cri du chat syndrome,
VerifiTM Plus 1
Standard VerifiTM + all chromosome
VerifiTM Plus 2
Standard VerifiTM + microdeletion
VerifiTM Plus 3
Standard VerifiTM + all chromosome + microdeletion
How the Process Works
Physician recommends and orders test for patient.
Requisition and Informed Consent forms are completed, patient proceeds to blood draw.
Blood sample and test request form are sent back to lab.
Lab processes and analyzes the sample.
Test results are sent to health care professional.